This week, NICE issued the final guideline on prostate cancer diagnosis and treatment, stating that ‘men with low-risk localised prostate cancer who are considered suitable for radical treatment should be first offered active surveillance'.
Dr Heather Payne, an oncologist from University College Hospital, said: ‘Currently, most active surveillance is done in secondary care, but more prostate cancer care will be moving into primary care.
‘GPs will be doing active surveillance. This involves measuring PSA levels every three months to check to see how prostate cancer is progressing in men diagnosed with early localised prostate cancer.
‘This allows you to delay radical treatment thus reducing the chances of any possible side-effects.'
‘Overall, this latest prostate cancer guidance is very welcome and will help to bring primary and secondary care closer together,' said Dr Payne.
Comment below and tell us what you think